Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Better living through microbes

Nature Biotechnology volume 23, pages 645–647 (2005)Cite this article

An Erratum to this article was published on 01 August 2005

Genetically engineered bacteria made biotech drugs possible. Now, they are becoming drugs in their own right, Monya Baker reports.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Fluorescent photomicrograph of antigen-presenting cells after engulfing wild-type L. monocytogenes.

Courtesy of Keith Bahjat, Cerus

References

  1. Steidler, L. et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289, 1352–1355 (2000).

    Article  CAS  Google Scholar 

  2. Steidler, L. et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. 21, 1785–1789 (2003).

    Article  Google Scholar 

  3. Nemunaitis, J. et al. Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Cancer Gene Ther. 10, 737–744 (2003).

    Article  CAS  Google Scholar 

  4. Brockstedt, D.G. et al. L. monocytogenes-based cancer vaccines that segregate immunogenicity from toxicity. Proc. Natl. Acad. Sci. USA 101, 13832–13837 (2004).

    Article  CAS  Google Scholar 

  5. Agrawal, N. et al. Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc. Natl. Acad. Sci. USA 101, 15172–15177 (2004).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. San Francisco

    Monya Baker

Authors
  1. Monya Baker
    View author publications

    Search author on:PubMed Google Scholar

Related links

Related links

Web links

Cerus Corporation

Flanders Interuniversity Institute of Biotechnology

Osel

Oragenics

Vion

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baker, M. Better living through microbes. Nat Biotechnol 23, 645–647 (2005). https://doi.org/10.1038/nbt0605-645

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0605-645

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing